PerkinElmer’s cannabis testing portfolio features best-in-class sample homogenization platforms, ICPMS, LCMSMS, Headspace-GCMS, UHPLC and FTIR instruments and consumables.

In the Cannabis Lab with Larry Beardsley from Nature Safe Labs

Sponsors and CROs have historically been responsible for ensuring full chain of custody for their own clinical supply even though the clinical supply is typically outside of their control.  It is the burden of the Sponsors and CROs to determine the most efficient way to do that. An eClinical Supply Chain Management platform provides Sponsors and CROs with the assurance that they are meeting their regulatory requirement of full chain of custody and more importantly ensures that all needed clinical supplies are available and all samples get where and when they are needed.

The impact an eClinical Supply Chain Management platform can have on your next clinical trial

Through the adoption of a data driven and automated CMC Dossier generation process, pharmaceutical companies can reduce time-to-market while delivering significant cost savings to the organization. Eliminate errors, duplicate data entry and verification, create a digital chain of evidence and significantly reduce time spent on CMC authoring.

Transforming CMC Dossier Creation

The importance of filtration in dissolution testing:
Jakub Koceba, a global product specialist for Lab Filtration at Cytiva, will discuss the importance of choosing the correct filter, the various filtration steps in manual and automated filtration, and sustainability in the products used.

The Importance of Filtration in Dissolution Testing

Allucent’s Katy Moore, Pharm. D., R.Ph. President, Clinical Pharmacology Modeling and Simulation, offers insightful commentary for small and mid-sized biotechs developing scientific breakthroughs. Learn from Katy’s expertise how applying modeling and simulation can improve drug development and help bring new therapies to light.

How Applying Modeling and Simulation Technologies Can Improve Drug Development

Wurster Fluid Bed Coating is one of the most utilized processes for microencapsulation of fine particles in pharmaceutical, dietary supplement, food, and other industries. Jared McDonald walks through a brief history of the invention of the process, what it is, and how it can be used to address specific needs for a product. A discussion of the importance of choosing an experienced CDMO follows.

Wurster Fluid Bed Coating and Contract Development/Manufacturing with Coating Place, Inc.

A growing proportion of drugs in the development pipeline nowadays start out life at small biotech companies, rather than big pharma businesses. While this means the biotechs are taking on more risk, they will also reap greater rewards in the event of success. When it comes to choosing your CDMO partner, there is no substitute for a careful selection process to determine the right CDMO to make and manage your precious potential drug. In this podcast, David Hall, Senior Director, Commercial Development at Lonza Small Molecules, provides insights on how small and emerging pharmaceutical and biotech companies can navigate the evolving pharma development pipeline.

CMC Challenges in the Evolving Small Molecule Development Pipeline

Join us for this informative session as expert, Lon Johnson of Colbert Packaging, shares industry insights on serialization and security in packaging – its history, current state, and the oncoming expectations in the war on counterfeit drugs.

Serialization, Secondary Packaging and the War on Counterfeit Drugs

Creating a new therapeutic drug can take a decade or more to get to patients. Antibody production and discovery play an integral role in setting the stage for success at later stages of development. If a high affinity, functional antibody candidate is discovered early, the timeline to a finished targeted and effective therapeutic drug may be significantly reduced. In this podcast we will go through the untold tales of antibody production and discovery, as well as how Twist has optimized a process for antibody production and screening for potential therapeutics.

Untold Tales Behind Therapeutic Antibody Production and Screening with Twist Bioscience

Sharon Suchotliff, associate principal at ZS and lead for patient centricity, discusses why patient centricity has become a business imperative for life sciences companies. Sharon delves into the measurement of patient centricity, provides examples of how different companies have approached this and ZS’s approach for Patient Outcomes Impact (POI).

The Business Case for Patient Centricity

Siemens Energy’s Christian Kirchner and Randy Moore will be talking about Dry Gas Seals. The Dry Gas Seals employed by Siemens Energy centrifugal compressors represent a significant advance in shaft sealing. The design integrates cutting-edge technology to enhance gas compressor reliability and features low fugitive emissions and improved rotor dynamics.

Unleashing the Power of Compressors - Understanding Dry Gas Seals

Mistakes in the QC lab come in many forms: forgotten samples, incorrect solvent levels, or not verifying correct system performance. These mistakes can lead to repeated procedures and possibly time-consuming investigations, compromising lab productivity and efficiency. When combined, the Alliance iS HPLC System and Empower Software version 3.8.0 provide several new features designed to reduce errors and improve productivity in QC labs. Join Neil Lander and Denise Heyburn as they provide an overview of the top three advanced capabilities unlocked by combining the intuitively simple Alliance iS HPLC System with the latest version of Empower Software.

3 Things You Didn’t Know You Could Do with the Alliance iS HPLC System and Empower Version 3.8.0

This episode will cover the principles and intricacies of the jet milling process. It will also highlight some of the challenges when micronizing for inhalation delivery, and give some possible solutions.

From Powder to Particles - Inhalation Particle Engineering With Jet Milling

Intensified continuous chromatography, a type of Multi-Column Chromatography (MCC), has emerged as a valuable technique in downstream bioprocessing that enables increases in productivity. In this podcast, MCC Product Specialist, Jennifer Knister, will discuss how adopting MCC can reduce costs, decrease suite time, and lead to higher resin utilization, along with why these benefits are particularly worthwhile in multi-product facilities.

Multi-Column Chromatography (MCC) in biomanufacturing, now and in the future

AI is Here – Considerations for How Your Brand’s Patient Support Services Will Be Impacted

HPIHanckeDTGMT20231013 - 145844 Recording

Unveiling the Power of Raman Spectroscopy for Real-Time Product Insight

In high-performance liquid chromatography (HPLC), it is common for bases and unreacted ionized silanols on silica-based columns to cause irreproducible retention, broad peaks, and peak tailing when working with basic analytes. David S. Bell, Lead Consultant at ASKkPrime LLC offers innovative HPLC strategies that can help mitigate such issues.

Modern HPLC Strategies: Improving Retention and Peak Shape for Basic Analytes

Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.

The Transformative Role of Medical Information in Customer Engagement

Boosting Patient Adherence: The Power of Clinical Support Programs

Metabolic Flux Analysis (MFA) is a powerful technique used to characterize metabolic phenotype driving to improved productivity in biomanufacturing. MFA is most powerful when absolute concentrations of the metabolic intermediates are measured, but doing so in practice is often impractical due to inherent limitations of conventional absolute quantitation by mass spectral analysis. Recently, advances in artificial intelligence (AI) have been applied to solving the problem of broad, untargeted, absolute quantitation in liquid chromatography-mass spectrometry (LC-MS). These new approaches extend readily to the determination of absolute concentrations of stable isotopically-labeled metabolic intermediates, offering a new tool for MFA. Dr Sam Yenne from Metalytics Inc., a company that specializes in the science of metabolic flux, has recently assessed and adopted Pyxis, a new tool for absolute quantitation of raw LC-MS data. Dr Yenne describes MFA, its utility in biopharmaceutical development, associated challenges and how Pyxis impacts those challenges. 

Bringing Scalability to Metabolic Flux Analysis using Machine Learning to Accelerate LC-MS Interpretation

Fuel flexibility in heavy-duty gas turbines: a key driver for energy transition

Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.

Beyond the Prescription: Pharma's Role in Digital Health Conversations

Dr. Christopher Bailey, Gencor’s Director of Scientific Affairs dives into the latest around the role of GLP-1 in systemic health. Dr. Bailey begins with outlining the current statistics around the prevalence of being overweight in the U.S., contributing factors, and lifestyle modifications that can help to address it. He will then highlight the importance of weight management to overall health and wellbeing. Lastly, Dr. Bailey helps to explain the current excitement around the GLP-1 pathway and how it can be tapped into to address metabolic health, with a clinically studied solution.

Implications of GLP-1 and Systemic Health

Imagine a world where cleanroom facilities—essential for pharmaceutical manufacturing, biotechnology, and high-tech industries—are built with unparalleled speed, precision, and efficiency. That world is here, thanks to the hybrid construction approach. By blending traditional stick-built methods with modular and prefabricated solutions, companies are overcoming the limitations of conventional construction while ensuring compliance with stringent industry regulations. In this interview, we explore how hybrid cleanroom construction is transforming the industry, offering faster project timelines, improved quality control, and significant cost advantages. Join us as we delve into this game-changing approach with industry experts who are leading the charge in revolutionizing cleanroom infrastructure.

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

ADC Cast: ADC antigen targets: What are we aiming at?

Being Ahead of Time

Ensuring API Quality Through a Robust Manufacturer Approval Process

Complex sample matrices in LC/MS/MS workflows can cause contamination, increase downtime, and make sample preparation more time-consuming, all of which impacts lab efficiency and reliability. PerkinElmer’s QSight® 500 LC/MS/MS System with StayClean™ Technology addresses these issues by reducing contamination and minimizing maintenance, enabling labs to effectively process challenging samples with greater consistency.

Break Free from Sample Prep and Contamination by Optimizing LC/MS/MS Workflows

Beyond repairs and maintenance: unlocking long-term value with OEM aftermarket support

An Innovative LIMS Cloud-Based Platform for Laboratory Research and Development

Lorna De Leoz, Agilent Global Food Segment Director, addresses the growing concern surrounding per- and polyfluoroalkyl substances (PFAS) in food supply. These “forever chemicals” accumulate in the environment and in people, and are associated with serious health risks including cancer and immune suppression. PFAS are notoriously difficult to detect and remove because they originate from multiple sources (water, soil, packaging) and encompass nearly 15,000 individual compounds. Because of their pervasive nature, laboratories must meet extremely low detection limits, meaning robust analytical testing is essential to managing exposure. Agilent is helping the industry address these challenges with simplified, scalable, end-to-end testing solutions, such as pass-through cleanup workflows and clean components, that reduce contamination risk and help laboratories stay ahead of regulatory demands.

Dedicated Dialogue

Popular tracks